No. There is no FDA-approved GLP-1 agonist available over the counter in the United States. Every approved GLP-1 medication, including Wegovy, Zepbound, Ozempic, and the oral options, is prescription-only and requires a licensed provider. Products sold OTC as "natural GLP-1 boosters" are supplements, not GLP-1 drugs, and work very differently.
If you are comparing what is available to buy, see our overview of GLP-1 products.
The appeal is obvious: skip the doctor, skip the prescription, buy a GLP-1 off the shelf. But that option does not legally exist, and the workarounds that look like it carry real risks. GLP-1 pills do now exist in the United States, which is where most of the confusion starts, but every one of them still needs a prescription. Here is what is actually available and what to avoid.
Is any GLP-1 agonist sold over the counter?
No FDA-approved GLP-1 receptor agonist can be bought without a prescription. This includes both injectable and oral forms.
Why GLP-1 drugs are prescription-only
GLP-1 medications affect blood sugar, digestion, and appetite, and they carry meaningful contraindications, including a boxed warning tied to certain thyroid cancers. The FDA classifies them as prescription drugs precisely because they need clinician evaluation, dosing supervision, and monitoring for side effects. That is true for the injections and for oral semaglutide tablets as well, despite the pill format making them feel more casual.
What "prescription-only" actually means
Prescription-only means a licensed provider must evaluate you and authorize the medication, but it does not mean the process is slow or inaccessible. Telehealth has made legitimate prescriptions fast and widely available. If you qualify, see our overview of the criteria a doctor checks before prescribing a GLP-1 and the realistic routes to getting a GLP-1 without your usual doctor.
Does this include GIP and dual-agonist drugs?
Yes. People ask about GIP separately because Zepbound and Mounjaro are not pure GLP-1 drugs. Tirzepatide "selectively binds to and activates both the GIP and GLP-1 receptors," in the words of its own FDA label, and it is sold only as an injection at 2.5, 5, 7.5, 10, 12.5, and 15 mg per 0.5 mL. There is no tablet version, and no version of it is available without a prescription.
The wider answer is the same in every direction. In the United States there is no over-the-counter GIP agonist, no over-the-counter dual GIP/GLP-1 agonist, and no approved standalone GIP drug at all. Retatrutide, the triple GIP/GLP-1/glucagon agonist people usually ask about next, is not FDA-approved for any use, so it is not an OTC product either. It is an unapproved drug, which is a weaker position than prescription-only, not a stronger one.
What about the compounded and grey-market GLP-1s online?
You may have seen websites selling "semaglutide" or "tirzepatide" without much of a process. This is the grey market, and the landscape changed significantly in 2025.
The compounding rules tightened
During the national shortage, compounding pharmacies were permitted to make copies of semaglutide and tirzepatide. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, then set wind-down deadlines. By May 2025 the grace periods for routine compounded semaglutide and tirzepatide had ended, sharply narrowing legal compounding. Some patient-specific compounding can still occur in limited circumstances, which we cover in our pieces on compounded tirzepatide and tirzepatide compounding pharmacies.
The counterfeit and no-prescription risk
Sites that ship a GLP-1 with no real prescription are a different and more dangerous category. The FDA and others have warned that many online sellers offering these drugs without a prescription are operating illegally, and that counterfeit products, often made abroad without oversight, have flooded the market. Reports suggest a large share of online pharmacies selling GLP-1s fail basic quality or licensing standards. Buying "research peptides" or no-questions-asked vials means you cannot verify the dose, purity, or sterility. We discuss why buying Ozempic without a prescription is risky in more detail.
What about ordering from overseas pharmacies?
A related temptation is importing a GLP-1 from a foreign pharmacy where it appears cheaper or easier to get. For personal use this sits in a legal grey zone, and it carries the same core problems as the domestic grey market: you cannot reliably verify that the product is genuine, correctly dosed, sterile, or stored properly in transit. Counterfeits frequently move through exactly these channels. A lower sticker price does not help if the vial contains the wrong amount of drug, a different substance, or nothing active at all.
"Registered with the FDA" is not the same as approved
Grey-market sellers lean hard on official-sounding proof: an NDC number, a screenshot of a government database entry, a certificate of analysis. None of that is approval, and the distinction is easy to check yourself.
Search DailyMed, the NIH-run database that hosts drug labeling submitted to the FDA, for retatrutide. You will find pens and lyophilized vials listed there by a cross-border e-commerce company based in Guangzhou. Open one of those records and the marketing category reads "Export only," with no application number attached to it. A listing record means a labeler filed paperwork describing a product. An approval means the FDA reviewed that product's safety and effectiveness and issued an application number for it. Only the second one tells you anything about what is in the vial, and no amount of database screenshots turns the first into the second.
How to spot an illegitimate seller
| Warning sign | What a legitimate provider does instead |
|---|---|
| No prescription or medical intake required | Requires a real evaluation by a licensed clinician |
| Sells "research only" peptides "not for human use" | Dispenses FDA-approved or properly compounded product |
| No U.S. pharmacy license or verifiable address | Lists licensing and is verifiable |
| An NDC number or database listing offered as proof of FDA approval | Can point to an actual approved application, by name and number |
| Prices far below every legitimate option | Pricing is in a believable range |
| Pressure to buy in bulk, crypto-only payment | Standard payment and normal quantities |
What OTC "alternatives" are marketed, and do they work?
Walk into any supplement aisle or scroll any ad feed and you will see products branded as "nature's Ozempic" or "GLP-1 support." These are legal to sell over the counter precisely because they are not GLP-1 drugs.
Berberine and other "nature's Ozempic" supplements
Berberine is the most common example. It is a plant compound that may have modest effects on blood sugar and metabolism in some studies, but it is not a GLP-1 receptor agonist and does not produce anything close to the weight loss seen with semaglutide or tirzepatide. Calling it "nature's Ozempic" is marketing, not pharmacology.
Fiber, protein, and appetite products
Other OTC products lean on soluble fiber (such as glucomannan), protein powders, or appetite-suppressing ingredients. These can support satiety and a healthy diet, but they act through bulk and fullness, not by activating the GLP-1 receptor. Any honest comparison shows a large gap in effect size.
Why these are not GLP-1 agonists
A true GLP-1 agonist binds the GLP-1 receptor to slow gastric emptying, increase satiety signaling, and improve insulin response. Supplements do not do this in any clinically meaningful way. They are sold over the counter because they are classified as dietary supplements, which are regulated far more loosely than drugs and are not held to the same evidence standard.
Which GLP-1 medications come as pills, and are any of them over the counter?
This is where the over-the-counter question has changed. GLP-1 pills are real, they are on the US market, and none of them is sold over the counter. Every oral GLP-1 approved in the United States is a prescription drug.
| Oral GLP-1 | Active ingredient | Tablet strengths | Approved for | How you get it |
|---|---|---|---|---|
| Rybelsus | oral semaglutide | 3 mg, 7 mg, 14 mg | Type 2 diabetes, plus reducing major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk | Prescription only |
| Wegovy tablets | oral semaglutide | 1.5 mg, 4 mg, 9 mg, 25 mg | Long-term weight management, plus reducing major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight | Prescription only |
| Foundayo | orforglipron | 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, 17.2 mg | Long-term weight management in adults with obesity, or overweight with at least one weight-related condition | Prescription only |
Novo Nordisk's oral semaglutide now sits on a single FDA label carrying two brand names, titled "OZEMPIC- oral semaglutide tablet RYBELSUS- oral semaglutide tablet," with the Ozempic tablet listed at 1.5 mg, 4 mg, and 9 mg. Different box, same prescription requirement.
Orforglipron is the newest pill, and it is still prescription-only
Foundayo (orforglipron) is Eli Lilly's once-daily oral GLP-1 receptor agonist. Its label describes it plainly: it "binds to and activates the human GLP-1 receptor." Dosing starts at 0.8 mg once daily and steps up no faster than every 30 days, to 2.5 mg, then 5.5 mg, and onward to a maximum of 17.2 mg daily. Tablets are swallowed whole, with or without food.
That last detail is the one practical advantage over semaglutide tablets, which have to be taken on an empty stomach in the morning with no more than 4 ounces of water, followed by a 30-minute wait before any food, drink, or other oral medication. Neither product is any less of a drug for being a tablet. Both carry the same boxed warning about thyroid C-cell tumors seen in rodents that the injections carry, and Foundayo is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. That contraindication is exactly the kind of thing a shelf cannot screen for and a prescriber can.
What about oral semaglutide tablets sold online as OTC?
This is a common point of confusion, so it deserves its own answer.
Prescription tablets versus supplement "tablets"
Real oral semaglutide (the active ingredient in Rybelsus and oral Wegovy) is a prescription drug, not an OTC product. Any website advertising "semaglutide tablets" you can buy without a prescription is either selling an unapproved grey-market product or a supplement using the name loosely. See our explainer on semaglutide tablets and the OTC question for the specifics.
The bottom line on pills
A pill format does not change the regulatory status. If it genuinely contains semaglutide, it requires a prescription. If it does not require a prescription, it is not real prescription semaglutide.
What is the safest way to actually get a GLP-1?
If you want a GLP-1 agonist, the only legitimate path is a prescription. The good news is that telehealth has made this faster and often more affordable than people expect. Start by confirming whether you meet the prescribing criteria, then compare cost across pharmacies and programs. Avoid any shortcut that skips a real medical evaluation, because the money you save can come at the cost of your safety.
In practice it is four steps:
- Check the criteria before you book anything. Approved weight-management GLP-1s are indicated for adults with obesity, or overweight plus at least one weight-related condition. Our page on the criteria a doctor checks walks through what gets asked.
- Get evaluated by a licensed clinician. In person or by telehealth. This is the step the grey market removes, and it is the step that catches thyroid history, pancreatitis history, and drug interactions.
- Fill at a licensed US pharmacy. The pharmacy should be verifiable, willing to state its license, and able to name the approved product it is dispensing.
- Compare cost after you have a prescription, not before. Manufacturer savings programs, cash-pay pharmacy channels, and oral versus injectable options can move the number substantially, and none of them require you to trust an anonymous seller.
Frequently Asked Questions
Can I buy Ozempic or Wegovy at a pharmacy without a prescription?
No. U.S. pharmacies cannot legally dispense Ozempic, Wegovy, Zepbound, or any other GLP-1 agonist without a valid prescription from a licensed provider.
Are there any GLP-1 pills over the counter?
No. GLP-1 pills exist, but not over the counter. Rybelsus, Wegovy tablets, and Foundayo (orforglipron) are all approved oral GLP-1 medications in the United States, and all three are prescription-only. Anything sold as a GLP-1 pill without a prescription is a dietary supplement or an unapproved product, not one of these drugs.
Is orforglipron (Foundayo) sold over the counter?
No. Foundayo is a prescription drug. It is a once-daily GLP-1 receptor agonist tablet approved for long-term weight management, taken with or without food, with doses escalating from 0.8 mg to a maximum of 17.2 mg daily under a prescriber's direction. It carries a boxed warning about thyroid C-cell tumors observed in rodents and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
How do you get GLP-1 medication if you cannot buy it over the counter?
Through a prescription, and the route is shorter than most people assume. Confirm you meet the prescribing criteria, get evaluated by a licensed clinician either in person or through telehealth, then fill at a licensed U.S. pharmacy and compare cost across manufacturer programs and cash-pay options. There is no legal version of this that skips the evaluation.
Is a GIP or dual GIP/GLP-1 agonist available in the US without a prescription?
No. Tirzepatide, the dual GIP and GLP-1 receptor agonist sold as Mounjaro and Zepbound, is injection-only and prescription-only. No standalone GIP agonist is approved in the United States at all, and retatrutide, the triple GIP/GLP-1/glucagon agonist, is not FDA-approved for any use, so it has no legal over-the-counter status either.
Is berberine the same as a GLP-1 drug?
No. Berberine is a dietary supplement, not a GLP-1 receptor agonist. It may have modest metabolic effects in some people, but it does not work like semaglutide or tirzepatide and does not produce comparable weight loss.
Are compounded GLP-1s legal now?
Routine compounding of semaglutide and tirzepatide largely ended in 2025 after the FDA declared the shortages resolved. Limited patient-specific compounding may still be allowed in narrow situations, but mass-market "compounded" sales without a prescription are a red flag.
Why are some websites selling GLP-1s without a prescription?
Because they are operating outside the law or selling unapproved or counterfeit products. The FDA has warned that many such sellers fail quality and licensing standards, so the product may be unsafe, mislabeled, or fake. Treat an NDC number or a database listing as paperwork, not approval.
This article is for general education and is not medical advice. Talk with a licensed healthcare provider before starting or sourcing any GLP-1 medication.
References
- WEGOVY (semaglutide) injection - Highlights of Prescribing Information (Boxed Warning: Risk of Thyroid C-Cell Tumors). U.S. Food and Drug Administration. FDA label
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. FDA
- FOUNDAYO (orforglipron) tablets - Prescribing Information (indication, boxed warning, dose escalation, administration). Eli Lilly and Company, via DailyMed. DailyMed
- WEGOVY (semaglutide) injection and tablet - Prescribing Information (tablet strengths 1.5 mg, 4 mg, 9 mg, 25 mg; oral administration instructions). Novo Nordisk, via DailyMed. DailyMed
- OZEMPIC / RYBELSUS (oral semaglutide) tablet - Prescribing Information (tablet strengths and indications). Novo Nordisk, via DailyMed. DailyMed
- ZEPBOUND (tirzepatide) injection - Prescribing Information (Mechanism of Action: activates both the GIP and GLP-1 receptors; injection strengths). Eli Lilly and Company, via DailyMed. DailyMed
- RETATRUTIDE PEN injection, solution (Marketing Category: Export only; labeler Guangzhou Yixin Cross-border E-commerce Co., Ltd.). DailyMed. DailyMed
